| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Sorafenib | GDSC1000 | pan-cancer | AAC | 0.16 | 0.003 |
| mRNA | RDEA119 | GDSC1000 | pan-cancer | AAC | 0.092 | 0.003 |
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | 0.14 | 0.003 |
| mRNA | AP-24534 | GDSC1000 | pan-cancer | AAC | 0.1 | 0.003 |
| mRNA | Bexarotene | FIMM | pan-cancer | AAC | 0.51 | 0.003 |
| mRNA | TPCA-1 | CTRPv2 | pan-cancer | AAC | 0.095 | 0.004 |
| mRNA | RITA | CTRPv2 | pan-cancer | AAC | 0.1 | 0.004 |
| mRNA | ATRA | FIMM | pan-cancer | AAC | 0.5 | 0.004 |
| mRNA | PD173074 | GDSC1000 | pan-cancer | AAC | 0.1 | 0.004 |
| mRNA | elocalcitol | CTRPv2 | pan-cancer | AAC | -0.098 | 0.005 |